Hospital Acquired Infection Control Market Is Anticipated to Grow Further Up to USD 26.8 Billion by 2032 |Olympus Corporation, Medivator, Getinge Group

The hospital-acquired infection control market was valued at USD 19.0 billion in 2022 and it is anticipated to grow further up to USD 26.8 billion by 2032, at a CAGR of 3.5% during the forecast period.

Download Free Sample of Report - https://www.globalinsightservices.com/request-sample/GIS10297

Nosocomially acquired illnesses that are not present or incubating at the time of admission to a hospital are known as hospital-acquired infections (HAIs). These infections include bloodstream infections linked to central lines, urinary tract infections linked to catheters, surgical site infections, pneumonia linked to ventilators, pneumonia acquired in hospitals, and infections with Clostridium difficile. A productive cough, shortness of breath, abdominal discomfort, rebound tenderness, altered mental status, palpitations, suprapubic pain, polyuria, dysuria, and costovertebral angle tenderness are signs that an infection is present.

Market Trends and Drivers

Some of the major factors driving this market are rising awareness about Hospital Acquired Infections (HAIs), the need to prevent cross-infections, the incidence of infectious diseases in healthcare facilities, and supportive government programs to encourage infection control techniques. The development of national, regional, and hospital-level infection prevention guidelines and policies as well as the expanding use of monitoring tools are both contributing to the expansion. Similarly, the market for hospital-acquired infection control is anticipated to grow as a result of factors including the increased demand for sterilization and disinfection in hospitals and clinics, technological developments in sterilization and disinfection equipment, an increase in hospitals outsourcing sterilization services to pharmaceutical and medical device companies, and an increase in the production of medical nonwovens and single-use products due to an increase in COVID-19 cases.

Major Players of the Global Hospital Acquired Infection Control Market

The key players analyzed in the market are Olympus Corporation, Medivators Inc. (Cantel Medical Corp.), Getinge Group, STERIS Plc., Belimed AG (Metall Zug), Steelco S.P.A, Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Advanced Sterilization Products Services Inc. (Johnson & Johnson), Abbott Laboratories, and Bayer AG among others.

COVID-19 Impact

The hospital-acquired infection control market was significantly impacted by the COVID-19 epidemic. In particular, hand sanitizers, disinfectants, PPE kits, masks, and gloves saw a spike in demand as a result. The prior year saw an increase in the demand for infection control goods and services. For instance, the Metall Zug Group disclosed the negative effects of the COVID-19 pandemic on its total company in August 2020. The corporation did see an increase in its infection control business division, though.

Request Customization- https://www.globalinsightservices.com/request-customization/GIS10297

Hospital acquired infections during the outbreak were observed to have decreased statistically significantly, according to a 2020 study on the Impact of the COVID-19 Pandemic on the HAI Rate in Iran. High employment of infection control technology, adherence to infection control procedures, isolation of infected patients, and the use of antimicrobial treatments to eradicate infection were all factors in the low occurrence of HAIs. The study also discovered that the low occurrence of nosocomial infections was due in part to increased awareness, ongoing education, and the use of suitable and effective infection control measures.

Global Hospital Acquired Infection Control Market Segmentation

By Products & Services

Sterilization
Cleaning & Disinfection Products
Protective Barriers
Endoscope Reprocessing Products

By Infection Type

Hospital-acquired Pneumonia
Bloodstream Infections
Surgical Site Infections
Gastrointestinal Infections
Urinary Tract Infections (UTI)
Others

By End User

Hospitals & Clinics
Ambulatory Surgical Centers
Others

Procure Complete Report (pdf with Insights, Charts, Tables, and Figures) https://www.globalinsightservices.com/checkout/single_user/GIS10297

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

This release was published on openPR.